O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
Nicholas P. Marotta(Institute on Aging), Matthew R. Pratt(University of Southern California), Maxwell T. Roth(University of Southern California), Balyn W. Zaro(University of California, San Francisco), Don B. Arnold(University of Southern California), Mark R. Ambroso(University of Southern California), Ralf Langen(Keck Hospital of USC), Yu Lin(University of Michigan–Ann Arbor), Yuka E. Lewis(University of Southern California)
Cited by 305
Related Papers
Fibril Structure of Human Islet Amyloid Polypeptide
|Journal of Biological Chemistry|2011|149
The role of N-glycosylation in cancer
|Acta Pharmaceutica Sinica B|2023|108
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
|Acta Neuropathologica Communications|2021|82
Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4–MyD88 Complex
|The Journal of Immunology|2019|67